Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Bullboard Posts
Post by JonEcashon Apr 24, 2012 4:25pm
277 Views
Post# 19830710

Nice close.

Nice close.

This stock is still VERY unknown, although that could be changing given the new posters we are getting now.  So those who are getting in now are positioned to make the most money if they can exercise some patience.  Some deep pockets have invested heavily here and they aren't holding out for pennies, and neither should the long-term holders here.

Sadly I didn't attend the AGM this year, but I was there last year and Phillip stated that target market cap to be a half billion dollars, at least.  And what are we now?  Like $30-$35M?  Getting to their goal would mean a share price of $4 (assuming no further dilution).  So let's be conservative and get to even 50% of that number and we are all going to be very happy...

Cheers!

J$

Bullboard Posts